Stockscreener 앱 받기
6.77
1.60%
-0.11
Karyopharm Therapeutics Inc (KPTI) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
26.37%
37.93
|
30.02 | 38.78 | 42.79 | 33.13 |
Operating Expenses
|
1.51%
62.32
|
63.27 | 65.07 | 70.91 | 66.89 |
| Benefits Costs and Expenses |
40.61%
75.14
|
53.44 | 70.83 | 18.93 | 70.42 |
| Costs And Expenses |
40.61%
75.14
|
53.44 | 70.83 | 18.93 | 70.42 |
| Operating Income/Loss |
26.67%
-24.39
|
-33.26 | -26.28 | -28.12 | -33.76 |
| Nonoperating Income/Loss |
230.47%
-12.82
|
9.83 | -5.761 | 51.98 | -3.532 |
| Income/Loss From Continuing Operations Before Tax |
58.85%
-37.21
|
-23.43 | -32.04 | 23.86 | -37.29 |
| Income Tax Expense/Benefit |
11.11%
0.04
|
0.036 | 0.028 | 0.067 | 0.071 |
| Income/Loss From Continuing Operations After Tax |
58.78%
-37.25
|
-23.46 | -32.07 | 23.79 | -37.36 |
|
Net Income/Loss
|
58.78%
-37.25
|
-23.46 | -32.07 | 23.79 | -37.36 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | 5.541 | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1.77%
0.00862
|
0.00847 | 0.125 | 121.03 | 115.45 |
| Diluted Average Shares |
1.77%
0.00862
|
0.00847 | 0.125 | 154.43 | 115.45 |
| Basic Earnings Per Share |
55.96%
-4.32
|
-2.77 | -0.26 | 0.15 | -0.32 |
| Diluted Earnings Per Share |
55.96%
-4.32
|
-2.77 | -0.26 | -0.20 | -0.32 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | 5.541 | - |
2.34%
자본화:
|
볼륨(24시간):